Maria Cassano had a dissociative disorder for 20 years, and had no idea because she thought she was just stressed out.
By reducing dissociation and sedation risk, ALA-3000 may eliminate the ≥2-hour post-dose monitoring requirement, reducing clinic operating costs, ...
This rant comes from an exhausted air traveller, who is still recovering from the trauma of spending almost as much time on a ...
Vietnam Investment Review on MSN
Alar reports positive Phase 1 results for long-acting ketamine therapy
TAICHUNG, April 6, 2026 /PRNewswire/ -- Alar Pharmaceuticals Inc. (Alar, TPEx:6785), a clinical-stage biopharmaceutical company focused on developing long-acting injectables (LAIs), today announced ...
Alar’s ketamine-based drug mitigates certain adverse events, which could eliminate the need for post-dose monitoring.
Police told the 62-year-old grandmother at an October No Kings rally that she didn't have the right to wear a costume from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results